adverse events

Open Access
Counteracting Side-effects of Photodynamic Therapy for Actinic Keratoses
HANS CHRISTIAN WULF and IDA M. HEERFORDT

Anticancer Research October 2022, 42 (10) 5017-5020; DOI: https://doi.org/10.21873/anticanres.16009
Open Access
Adverse Events in Placebo Arms of Cancer Trials
JOHANNES E. WOLFF, BIRTE J. WOLFF, MARCEAL M. THIELEN and HOLGER HAUCH

Anticancer Research June 2022, 42 (6) 2805-2812; DOI: https://doi.org/10.21873/anticanres.15761
You have access
Usefulness of Medication Guidance Sheets for Patients With Non-Hodgkin’s Lymphoma Receiving ESHAP±R Therapy
MAYAKO UCHIDA, SAEKO MURATA, HANAE MORIKAWA, HIROKO YONEMITSU, SHIGERU ISHIDA, KIMITAKA SUETSUGU, TOSHIKAZU TSUJI, HIROYUKI WATANABE, TAKEHIRO KAWASHIRI, KOJI KATO, KEIKO HOSOHATA, TOSHIHIRO MIYAMOTO, NOBUAKI EGASHIRA, TSUTOMU NAKAMURA, KOICHI AKASHI and ICHIRO IEIRI

Anticancer Research April 2022, 42 (4) 2053-2060; DOI: https://doi.org/10.21873/anticanres.15686
You have access
The Role of Community Pharmacists in Addressing Medication-related Issues for Breast Cancer Patients Receiving Adjuvant Endocrine Therapy
KINAN MOKBEL and KEFAH MOKBEL

Anticancer Research February 2022, 42 (2) 661-666; DOI: https://doi.org/10.21873/anticanres.15524
You have access
Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan
NAOTAKA SHIMOZATO, TADASHI NAMISAKI, AKIHIRO OKANO, MASAYA OHANA, DAISUKE KINOSHITA, TOSHIHIKO KAWASAKI, YOSUKE AIHARA, TOSHIYA NAKATANI, HIROKI KINOSHITA, TATSUICHI ANN, KO SAITO, MOTOYUKI YOSHIDA and HITOSHI YOSHIJI

Anticancer Research January 2022, 42 (1) 173-183; DOI: https://doi.org/10.21873/anticanres.15471
You have access
Fatigue in Cancer Treatment Studies: Analysis of Placebo Arms
HOLGER HAUCH, BIRTE J. WOLFF and JOHANNES E. WOLFF

Anticancer Research January 2022, 42 (1) 45-52; DOI: https://doi.org/10.21873/anticanres.15455
You have access
Response to Platinum-based Chemotherapy Rechallenge for Patients With Pembrolizumab-refractory Urothelial Carcinoma
TETSUYA YUMIOKA, MASASHI HONDA, RYUTARO SHIMIZU, SHOGO TERAOKA, NORIYA YAMAGUCHI, BUNYA KAWAMOTO, HIDETO IWAMOTO, SHUICHI MORIZANE, KATSUYA HIKITA and ATSUSHI TAKENAKA

Anticancer Research November 2021, 41 (11) 5767-5773; DOI: https://doi.org/10.21873/anticanres.15393
You have access
Anemia in Placebo Arms of Cancer Studies
JOHANNES E. WOLFF

Anticancer Research September 2021, 41 (9) 4543-4548; DOI: https://doi.org/10.21873/anticanres.15266
You have access
Adverse Events and Economic Burden Among Patients Receiving Systemic Treatment for Mantle Cell Lymphoma: A Real-World Retrospective Cohort Study
SHAUM M. KABADI, STACEY DACOSTA BYFIELD, LISA LE and TEMITOPE OLUFADE

Anticancer Research February 2021, 41 (2) 927-936; DOI: https://doi.org/10.21873/anticanres.14846
You have access
Relationship Between Renal Function and the Incidence of Adverse Events in Patients With Colorectal Cancer Receiving Oxaliplatin
DAICHI WATANABE, HIRONORI FUJII, YUNAMI YAMADA, HIROTOSHI IIHARA, TAKUMA ISHIHARA, NOBUHISA MATSUHASHI, TAKAO TAKAHASHI, KAZUHIRO YOSHIDA and AKIO SUZUKI

Anticancer Research January 2020, 40 (1) 299-304; DOI: https://doi.org/10.21873/anticanres.13953

Main menu

User menu

Search

adverse events

Pages